Cellectis S.A. (CLLS)
NASDAQ: CLLS · IEX Real-Time Price · USD
1.890
-0.045 (-2.33%)
At close: Jul 2, 2024, 3:57 PM
2.100
+0.210 (11.11%)
After-hours: Jul 2, 2024, 7:54 PM EDT
Cellectis Market Cap
Cellectis has a market cap or net worth of $125.41 million as of July 2, 2024. Its market cap has increased by 26.81% in one year.
Market Cap
125.41M
Enterprise Value
-75.00M
1-Year Change
26.81%
Ranking
Category
Stock Price
$1.89
Market Cap Chart
Since March 25, 2015, Cellectis's market cap has decreased from $1.34B to $125.41M, a decrease of -90.67%. That is a compound annual growth rate of -22.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 136.40M | -20.33% |
| Dec 29, 2023 | 171.20M | 78.89% |
| Dec 30, 2022 | 95.70M | -74.09% |
| Dec 31, 2021 | 369.30M | -67.88% |
| Dec 31, 2020 | 1.15B | 58.27% |
| Dec 31, 2019 | 726.40M | 2.87% |
| Dec 31, 2018 | 706.10M | -31.45% |
| Dec 29, 2017 | 1.03B | 72.73% |
| Dec 30, 2016 | 596.30M | -43.80% |
| Dec 31, 2015 | 1.06B | -21.04% |
| Mar 25, 2015 | 1.34B | - |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Quipt Home Medical | 137.08M |
| ProQR Therapeutics | 135.56M |
| Adagene | 135.04M |
| Invivyd | 131.25M |
| Electromed | 130.10M |
| Amylyx Pharmaceuticals | 129.21M |
| I-Mab | 128.63M |
| Harvard Bioscience | 123.77M |